When should albumin be administered after paracentesis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albumin Administration After Paracentesis

Albumin should be administered after large volume paracentesis (>5 liters) at a dose of 8 g albumin per liter of ascites removed to prevent post-paracentesis circulatory dysfunction and associated complications. 1, 2

Dosing Guidelines Based on Volume Removed

  • Large volume paracentesis (>5 liters): Administer albumin at 8 g/L of ascites removed (e.g., 100 ml of 20% albumin per 2.5 liters of ascites) 1, 2
  • Modest volume paracentesis (<5 liters):
    • Standard patients: A synthetic plasma expander is recommended 1
    • High-risk patients (acute-on-chronic liver failure): Consider albumin at 8 g/L even for volumes <5 liters 3

Administration Protocol

  • Infuse albumin after paracentesis is completed, not during the procedure 2
  • Use 20% or 25% albumin solution for infusion 1, 2
  • Complete the paracentesis in a single session, draining ascites to dryness over 1-4 hours 1, 2
  • Reintroduce diuretics within 1-2 days after paracentesis to prevent ascites recurrence 1

Clinical Rationale

  • Albumin prevents post-paracentesis circulatory dysfunction (PICD), which can lead to serious complications including 1, 2:

    • Renal impairment
    • Hyponatremia
    • Hepatorenal syndrome
    • Increased mortality
  • Studies show significantly higher rates of renal impairment, hyponatremia, and activation of the renin-angiotensin-aldosterone system in patients not treated with albumin after large volume paracentesis 1

  • A meta-analysis of 17 randomized studies (1225 patients) showed albumin infusion reduced the odds of PICD by 61%, hyponatremia by 42%, and mortality by 36% compared to alternative treatments 1

Special Considerations

  • Albumin vs. synthetic plasma expanders: While synthetic plasma expanders show some clinical effectiveness, albumin is superior in preventing hyponatremia (8% vs 17% incidence) and shows less activation of the renin-angiotensin-aldosterone system 1

  • Patients with acute-on-chronic liver failure: These patients may develop PICD even with modest-volume paracentesis (<5L) and benefit from albumin infusion 3

  • Cost considerations: Despite higher upfront costs, albumin administration decreases liver-related complications and can reduce overall hospital costs compared to artificial plasma expanders 1

  • Dose optimization: Some evidence suggests that half-dose albumin (4 g/L) may be effective in patients with low severity cirrhosis, but standard dosing remains recommended until more conclusive evidence is available 1

Potential Pitfalls

  • Leaving drain in overnight: This is not recommended and may increase complications 2

  • Failure to monitor for circulatory dysfunction: Monitor for hypotension, which can occur (though rarely) after paracentesis 1

  • Exceeding safe volume removal: Consider limiting ascites removal to <8 liters during a single paracentesis procedure to minimize PICD risk 1

  • Infusion rate: Administer albumin slowly to prevent potential cardiac overload, especially in patients with pre-existing cardiomyopathy 1

While one meta-analysis questioned albumin's effect on mortality 4, the preponderance of evidence and current guidelines strongly support albumin administration after large volume paracentesis to prevent complications and improve outcomes 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.